Skip Navigation


Brain Advance Access originally published online on July 22, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary data
Right arrow All Versions of this Article:
126/10/2291    most recent
awg231v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (76)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Josephs, K. A.
Right arrow Articles by Revesz, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Josephs, K. A.
Right arrow Articles by Revesz, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 126, No. 10, 2291-2303, October 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg231

Neurofilament inclusion body disease: a new proteinopathy?

Keith A. Josephs1,5,7, Janice L. Holton7, Martin N. Rossor5, Hans Braendgaard8, Tetsutaro Ozawa6,7, Nick C. Fox5, Ronald C. Petersen1, Gary S. Pearl4, Milan Ganguly7, Pedro Rosa8, Henning Laursen9, Joseph E. Parisi1,2, Gunhild Waldemar9, Niall P. Quinn6, Dennis W. Dickson1,3 and Tamas Revesz7

Departments of 1 Neurology, 2 Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN and 3 Department of Pathology (Neuropathology), Mayo Clinic, Jacksonville, FL, 4 Department of Pathology, Orlando Regional Medical Center, Orlando, FL, USA, 5 Dementia Research Group, 6 Department of Motor Neuroscience and Movement Disorders and 7 Queen Square Brain Bank, Department of Molecular Neuroscience and Division of Neuropathology, Institute of Neurology, University College London, London, UK, 8 Aarhus Kommunehospital, Aarhus and 9 Copenhagen University Hospital, Copenhagen, Denmark

Correspondence to: Tamas Revesz, MD, Division of Neuropathology, Institute of Neurology, University College London, London WC1N 3BG, UK E-mail: t.revesz{at}ion.ucl.ac.uk

We describe four cases of a new clinicopathological entity presenting with either a frontotemporal dementia or corticobasal degeneration syndrome with a mean age of onset of 45 years (range 41–50) characterized pathologically by deposition of neurofilament proteins. All four patients had a rapidly progressive course and have become mute and non-ambulatory, and three have died after mean illness duration of only 3 years (range 21/2–4). Both structural (MRI) and functional (PET and SPECT) imaging demonstrated frontal and temporal lobe and basal ganglia involvement. Gross neuropathological examination in the three deceased patients (the fourth patient, still alive, was diagnosed by brain biopsy) revealed changes affecting predominantly the frontal and temporal cortices, basal ganglia and brainstem. There was superficial linear spongiosis affecting the frontal lobes in all three autopsied patients, and severe caudate atrophy was noted in two of them and demonstrated on MRI in the living patient. On routine staining, there were numerous intracytoplasmic inclusions, which ranged from eosinophilic to basophilic. Some had a clearly defined basophilic margin, while others were granular with a hyaline core. With modified Bielschowsky silver technique, a small number of the inclusions were intensely stained. Inclusions were not labelled with other silver stains. Immuno histochemistry revealed that the inclusions were immunoreactive with antibodies to neurofilament heavy and light chain subunits and to ubiquitin, but not with antibodies to tau and {alpha}-synuclein. These neurofilament- and ubiquitin-positive inclusions were widespread, specific to neurons and occasionally intranuclear. The frequency and distribution of the inclusions and the silver and immunohistochemical profiles in these four cases is novel and has not been described in detail before. We propose the term neurofilament inclusion body disease for this entity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arch NeurolHome page
D. O. Claassen, K. A. Josephs, and P. J. Peller
The Stripe of Primary Lateral Sclerosis: Focal Primary Motor Cortex Hypometabolism Seen on Fluorodeoxyglucose F18 Positron Emission Tomography
Arch Neurol, January 1, 2010; 67(1): 122 - 125.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
I. R. A. Mackenzie, D. Foti, J. Woulfe, and T. A. Hurwitz
Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions
Brain, May 1, 2008; 131(5): 1282 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
L. Molina-Porcel, A. Llado, M. J. Rey, J. L. Molinuevo, M. Martinez-Lage, F. X. Esteve, I. Ferrer, E. Tolosa, and R. Blesa
Clinical and Pathological Heterogeneity of Neuronal Intermediate Filament Inclusion Disease
Arch Neurol, February 1, 2008; 65(2): 272 - 275.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
B. L. Miller, K. A. Josephs Jr, J. E. Parisi, and B. M. Keegan
A 34-year-old man with progressive behavioral and language disturbance
Neurology, January 2, 2007; 68(1): 68 - 74.
[Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. Yuan, M. V. Rao, T. Sasaki, Y. Chen, A. Kumar, Veeranna, R. K. H. Liem, J. Eyer, A. C. Peterson, J.-P. Julien, et al.
{alpha}-Internexin Is Structurally and Functionally Associated with the Neurofilament Triplet Proteins in the Mature CNS
J. Neurosci., September 27, 2006; 26(39): 10006 - 10019.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
M. Mascalchi, C. Gavazzi, M. Morbin, G. Giaccone, G. Arnetoli, R. Zappoli, and O. Bugiani
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1037 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
P. Castillo, B. Woodruff, R. Caselli, S. Vernino, C. Lucchinetti, J. Swanson, J. Noseworthy, A. Aksamit, J. Carter, J. Sirven, et al.
Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis
Arch Neurol, February 1, 2006; 63(2): 197 - 202.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. A. Josephs, R. C. Petersen, D. S. Knopman, B. F. Boeve, J. L. Whitwell, J. R. Duffy, J. E. Parisi, and D. W. Dickson
Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP
Neurology, January 10, 2006; 66(1): 41 - 48.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
H. Uchikado, G. Shaw, D.-S. Wang, and D. W. Dickson
Screening for neurofilament inclusion disease using {alpha}-internexin immunohistochemistry
Neurology, May 10, 2005; 64(9): 1658 - 1659.
[Full Text] [PDF]

Home page
 BrainHome page
B. F. Boeve, I. W. Tremont-Lukats, A. J. Waclawik, J. R. Murrell, B. Hermann, C. R. Jack Jr, M. M. Shiung, G. E. Smith, A. R. Nair, N. Lindor, et al.
Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation
Brain, April 1, 2005; 128(4): 752 - 772.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
K. A. Josephs, D. F. Tang-Wai, S. D. Edland, D. S. Knopman, D. W. Dickson, J. E. Parisi, R. C. Petersen, C. R. Jack Jr, and B. F. Boeve
Correlation Between Antemortem Magnetic Resonance Imaging Findings and Pathologically Confirmed Corticobasal Degeneration
Arch Neurol, December 1, 2004; 61(12): 1881 - 1884.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. C. Paviour, A. J. Lees, K. A. Josephs, T. Ozawa, M. Ganguly, C. Strand, A. Godbolt, R. S. Howard, T. Revesz, and J. L. Holton
Frontotemporal lobar degeneration with ubiquitin-only-immunoreactive neuronal changes: broadening the clinical picture to include progressive supranuclear palsy
Brain, November 1, 2004; 127(11): 2441 - 2451.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. T. DeKosky and M. D. Ikonomovic
NIFID: A new molecular pathology with a frontotemporal dementia phenotype
Neurology, October 26, 2004; 63(8): 1348 - 1349.
[Full Text] [PDF]

Home page
 NeurologyHome page
N. J. Cairns, M. Grossman, S. E. Arnold, D. J. Burn, E. Jaros, R. H. Perry, C. Duyckaerts, B. Stankoff, B. Pillon, K. Skullerud, et al.
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease
Neurology, October 26, 2004; 63(8): 1376 - 1384.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. J. Cairns, V. Zhukareva, K. Uryu, B. Zhang, E. Bigio, I. R.A. Mackenzie, M. Gearing, C. Duyckaerts, H. Yokoo, Y. Nakazato, et al.
{alpha}-Internexin Is Present in the Pathological Inclusions of Neuronal Intermediate Filament Inclusion Disease
Am. J. Pathol., June 1, 2004; 164(6): 2153 - 2161.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. Lin, J. Zhai, R. Canete-Soler, and W. W. Schlaepfer
3' Untranslated Region in a Light Neurofilament (NF-L) mRNA Triggers Aggregation of NF-L and Mutant Superoxide Dismutase 1 Proteins in Neuronal Cells
J. Neurosci., March 17, 2004; 24(11): 2716 - 2726.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
E L Sampson, J D Warren, and M N Rossor
Young onset dementia
Postgrad. Med. J., March 1, 2004; 80(941): 125 - 139.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.